How to buy iHuman (IH) stock

iHuman Inc is an education & training services business based in the US. iHuman shares (IH) are listed on the NYSE and all prices are listed in US Dollars. iHuman employs 817 staff and has a trailing 12-month revenue of around 0.00.

iHuman stock price (NYSE: IH)

Use our graph to track the performance of IH stocks over time.

iHuman shares at a glance

• Key figures

Information last updated 2021-07-23.

Latest market close	$8.96
52-week range	$8.94 - $30.00
50-day moving average	$10.24
200-day moving average	$13.88
Wall St. target price	$11.46
PE ratio	N/A
Dividend yield	N/A (0%)
Earnings per share (TTM)	$-0.13

Buy iHuman shares from these brokerages

Compare special offers, low fees and a wide range of types of investments among top trading platforms.

*Signup bonus information updated weekly.

Is it a good time to buy iHuman stock?

The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.

Technical Analysis of iHuman Inc by TradingView

This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.

iHuman price performance over time

Historical closes compared with the close of $8.96 from 2021-05-28

1 week (2021-07-13)	N/A
1 month (2021-06-24)	-12.76%
3 months (2021-04-20)	N/A
6 months (2021-01-20)	N/A

1 year (2020-07-20)	N/A
2 years (2019-07-20)	N/A
3 years (2018-07-20)	N/A
5 years (2016-07-20)	N/A

Is iHuman under- or over-valued?

Valuing iHuman stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of iHuman's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.

iHuman's EBITDA

iHuman's EBITDA (earnings before interest, taxes, depreciation and amortisation) is $2 million.

The EBITDA is a measure of a iHuman's overall financial performance and is widely used to measure a its profitability.

To put iHuman's EBITDA into context you can compare it against that of similar companies.

• Stride (LRN.US): USD$138 million
• HCA Healthcare (HCA.US): USD$12.1 billion
• Grand Canyon Education (LOPE.US): USD$311 million
• Chegg (CHGG.US): USD$141.6 million

iHuman financials

Revenue TTM	$680.6 million
Gross profit TTM	$365.4 million
Return on assets TTM	-3.39%
Return on equity TTM	-10.96%
Profit margin	-4.23%
Book value	$12.38
Market capitalisation	$559.4 million

TTM: trailing 12 months

Shorting iHuman shares

There are currently 132,643 iHuman shares held short by investors – that's known as iHuman's "short interest". This figure is 1.9% up from 130,170 last month.

There are a few different ways that this level of interest in shorting iHuman shares can be evaluated.

iHuman's "short interest ratio" (SIR)

iHuman's "short interest ratio" (SIR) is the quantity of iHuman shares currently shorted divided by the average quantity of iHuman shares traded daily (recently around 58691.592920354). iHuman's SIR currently stands at 2.26. In other words for every 100,000 iHuman shares traded daily on the market, roughly 2260 shares are currently held short.

To gain some more context, you can compare iHuman's short interest ratio against those of similar companies.

• Stride (LRN.US): 5.83
• HCA Healthcare (HCA.US): 2.69
• Grand Canyon Education (LOPE.US): 3.14
• Chegg (CHGG.US): 9.56

However iHuman's short interest can also be evaluated against the total number of iHuman shares, or, against the total number of tradable iHuman shares (the shares that aren't held by "insiders" or major long-term shareholders – also known as the "float"). In this case iHuman's short interest could be expressed as 0% of the outstanding shares (for every 100,000 iHuman shares in existence, roughly 0 shares are currently held short) or 0.0093% of the tradable shares (for every 100,000 tradable iHuman shares, roughly 9 shares are currently held short).

Such a low SIR usually points to an optimistic outlook for the share price, with fewer people currently willing to bet against iHuman.

Find out more about how you can short iHuman stock.

iHuman share dividends

We're not expecting iHuman to pay a dividend over the next 12 months.

You may also wish to consider:

• HCA Healthcare (HCA.US) (0.39% forward annual dividend yield)

iHuman overview

iHuman Inc. provides childhood edutainment products and services to individual users, education organizations, and distributors in the People's Republic of China. The company offers interactive and self-directed learning apps, including iHuman Chinese, iHuman English, iHuman Pinyin, iHuman Magic Math, iHuman Books, and iHuman Stories. It also provides learning materials in physical and digital formats; and learning devices. The company was founded in 1996 and is based in Beijing, the People's Republic of China. .

Frequently asked questions

What percentage of iHuman is owned by insiders or institutions?
Currently 13.048% of iHuman shares are held by insiders and 10.738% by institutions. How many people work for iHuman?
Latest data suggests 817 work at iHuman. When does the fiscal year end for iHuman?
iHuman's fiscal year ends in December. Where is iHuman based?
iHuman's address is: Floor 8, Building 2, Beijing, China, 100102